Case Studies

Proof, not promises.

A selection of ophthalmology, medical device, IVD, nutraceutical and cosmetics programs where Proclin delivered against tight timelines, complex endpoints and demanding regulators.

Ophthalmology

Decentralized Phase III in Retinal Disease

A pivotal Phase III program in a retinal indication delivered ahead of timeline through home-based OCT capture and central blinded reading.

Duration

18 months

Footprint

12 sites, 3 countries

Outcome

40% faster enrollment vs benchmark

Devices & IVD

IVD Performance Study for a Molecular Diagnostic

A performance-evaluation study for a molecular IVD delivered CDSCO-ready evidence and a clean first-cycle submission.

Duration

9 months

Footprint

6 tertiary hospital labs

Outcome

CDSCO approval on first submission

Ophthalmology

AI Feasibility for all Glaucoma / Dry-Eye Combination Program

AI-driven feasibility scoring compressed a global sponsor's site-selection cycle from 12 weeks to 8 for a combination ophthalmology program.

Duration

8 weeks (feasibility)

Footprint

20 sites shortlisted

Outcome

Study start-up 10 weeks earlier

Cosmetics

HRIPT & Ophthalmic Tolerance for a Sensitive-Skin Serum

A dermatology-led safety and tolerance study delivered claim-ready evidence for a sensitive-skin serum across dermal patch, HRIPT and ophthalmic tolerance modules.

Duration

3 months

Footprint

1 dermatology unit

Outcome

Non-irritating, non-sensitizing claim

Nutraceutical

Bioavailability Trial for a Novel Curcumin Formulation

A randomized cross-over PK study established clean claim-substantiation evidence for a novel curcumin delivery system, aligned to FSSAI and DCGI expectations.

Duration

5 months

Footprint

2 India sites, 60 subjects

Outcome

6.4x higher bioavailability vs standard

Working on an ophthalmology, device, IVD, nutraceutical or cosmetics program? We'll walk you through the closest match in our portfolio under NDA.

Request a Portfolio Walkthrough